Your session is about to expire
← Back to Search
Plasma Scalpel
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
N/A
Waitlist Available
Research Sponsored by Jerome Canady, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate after application of cold plasma, followed by 3 months, 6 months, 12 months and 15 month observations.
Awards & highlights
No Placebo-Only Group
Summary
This trial is designed to study the safety of a new cold plasma scalpel in patients with solid tumors and metastatic disease.
Eligible Conditions
- Breast Cancer Stage IV
- Kidney Cancer
- Rectal Cancer
- Ovarian Cancer
- Liver Cancer
- Pancreatic Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Bladder Cancer
- Gastric Cancer
- Solid Tumors
- Colon Cancer
- Small Intestinal Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediate after application of cold plasma, followed by 3 months, 6 months, 12 months and 15 month observations.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate after application of cold plasma, followed by 3 months, 6 months, 12 months and 15 month observations.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Participants With Complications Due To Cold Plasma Application
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Primary ArmExperimental Treatment1 Intervention
After the gross solid tumor is removed, cold plasma is sprayed in the area of the resected tumor margins.
Find a Location
Who is running the clinical trial?
Jerome Canady, M.D.Lead Sponsor